Ausgabe 11-12/1997
Inhalt (22 Artikel)
Gammahydroxybutyrate (GHB) receptor ligand effects on evoked synaptic field potentials in CA1 of the rat hippocampal slice
M. A. King, J. S. Thinschmidt, D. W. Walker
Glycine and D-serine decrease MK-801-induced hyperactivity in mice
M. Nilsson, A. Carlsson, M. L. Carlsson
The glutamate antagonist Riluzole suppresses intracortical facilitation
J. Liepert, P. Schwenkreis, M. Tegenthoff, J. -P. Malin
Biotransformation of locally applied precursors of dopamine, serotonin and noradrenaline in striatum and hippocampus: A microdialysis study
S. Sarre, I. Smolders, K. Thorré, G. Ebinger, Y. Michotte
Prolonged deficits in presynaptic serotonin function following withdrawal from chronic cocaine exposure as revealed by 5-HTP-induced head-twitch response in mice
N. A. Darmani, J. Shaddy, E. L. Elder
Protection against post-ischaemic neuronal loss in gerbil hippocampal CA1 by glycine b and AMPA antagonists
J. W. Łazarewicz, R. Gadamski, C. G. Parsons, W. Danysz
Increased synaptic availability of norepinephrine following desipramine is not essential for increases in GR mRNA
A. Eiring, F. Sulser
The 5-HT transporter gene-linked polymorphic region (5-HTTLPR) in evolutionary perspective: Alternative biallelic variation in rhesus monkeys
K. P. Lesch, J. Meyer, K. Glatz, G. Flügge, A. Hinney, J. Hebebrand, S. M. Klauck, A. Poustka, F. Poustka, D. Bengel, R. Mössner, P. Riederer, A. Heils
Immunocytochemical study of catecholaminergic neurons in the senescence-accelerated mouse (SAM-P8) brain
N. Karasawa, I. Nagatsu, K. Sakai, T. Nagatsu, K. Watanabe, M. Onozuka
Reduction of lipid peroxidation in different brain regions by a combination of α-tocopherol and ascorbic acid
S. Bano, M. S. Parihar
Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Parkinson's disease
J. A. Molina, F. de Bustos, F. J. Jiménez-Jiménez, J. Benito-León, M. Ortí-Pareja, T. Gasallo, A. Tallón-Barranco, J. A. Navarro, J. Arenas, R. Enríquez-de-Salamanca
Is seborrhea a sign of autonomic impairment in Parkinson's disease?
E. Martignoni, L. Godi, C. Pacchetti, E. Berardesca, G. P. Vignoli, G. Albani, F. Mancini, G. Nappi
Clozapine-induced agranulocytosis and thrombopenia in a patient with dopaminergic psychosis
J. Rudolf, M. Grond, M. Neveling, W. -D. Heiss
Catechol-O-methyltransferase genotype and susceptibility to Parkinson's disease in Japan
A. Yoritaka, N. Hattori, H. Yoshino, Y. Mizuno
Ameliorative influence of a nootropic drug on motor activity of rats after bilateral carotid artery occlusion
A. Gschanes, V. Valoušková, M. Windisch
Elevated protein levels of protein phosphatases PP-2A and PP-2B in astrocytes of Alzheimer's disease temporal cortex
J. -J. Pei, I. Grundke-Iqbal, K. Iqbal, N. Bogdanovic, B. Winblad, R. F. Cowburn
The effect of fenfluramine dosage regimen and reduced food intake on levels of 5-HT in rat brain
S. Rose, J. G. Hindmarsh, P. Collins, P. Jenner
Unchanged density of caudate nucleus dopamine uptake sites in depressed suicide victims
P. Allard, M. Norlén
Decreases in peripheral-type benzodiazepine receptors in postmortem brains of chronic schizophrenics
A. Kurumaji, T. Wakai, M. Toru
Changes in protein kinase C and adenylate cyclase in the temporal lobe from subjects with schizophrenia
B. Dean, K. Opeskin, G. Pavey, C. Hill, N. Keks